D C Ansardi

841 total citations
21 papers, 688 citations indexed

About

D C Ansardi is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Genetics. According to data from OpenAlex, D C Ansardi has authored 21 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 14 papers in Infectious Diseases and 12 papers in Genetics. Recurrent topics in D C Ansardi's work include Viral Infections and Immunology Research (18 papers), Viral gastroenteritis research and epidemiology (14 papers) and Virus-based gene therapy research (12 papers). D C Ansardi is often cited by papers focused on Viral Infections and Immunology Research (18 papers), Viral gastroenteritis research and epidemiology (14 papers) and Virus-based gene therapy research (12 papers). D C Ansardi collaborates with scholars based in United States. D C Ansardi's co-authors include Casey D. Morrow, Donna C. Porter, Nava Epstein, Zina Moldoveanu, A. Gregory Matera, Xiangwei Xiao, Xiaodong Zhu, R. Jude Samulski, Chao Yang and Won Suk Choi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Virology.

In The Last Decade

D C Ansardi

20 papers receiving 670 citations

Peers

D C Ansardi
Donna C. Porter United States
Marion S. Freistadt United States
N Moscufo United States
B M Detjen United States
I Ise Japan
Christopher T. Cornell United States
Jörg Enssle Germany
Sylvain de Breyne France
Bernd Maurer Germany
Hyung Suk Oh United States
Donna C. Porter United States
D C Ansardi
Citations per year, relative to D C Ansardi D C Ansardi (= 1×) peers Donna C. Porter

Countries citing papers authored by D C Ansardi

Since Specialization
Citations

This map shows the geographic impact of D C Ansardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D C Ansardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D C Ansardi more than expected).

Fields of papers citing papers by D C Ansardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D C Ansardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D C Ansardi. The network helps show where D C Ansardi may publish in the future.

Co-authorship network of co-authors of D C Ansardi

This figure shows the co-authorship network connecting the top 25 collaborators of D C Ansardi. A scholar is included among the top collaborators of D C Ansardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D C Ansardi. D C Ansardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morrow, Casey D., D C Ansardi, & Donna C. Porter. (2003). Methods for the Use of Poliovirus Vectors for Gene Delivery. Humana Press eBooks. 7. 103–116.
3.
Ansardi, D C, et al.. (2001). RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse origins.. PubMed. 61(23). 8470–9. 22 indexed citations
4.
Morrow, Casey D., Miroslav Novák, D C Ansardi, Donna C. Porter, & Zina Moldoveanu. (1999). Recombinant Viruses as Vectors for Mucosal Immunity. Current topics in microbiology and immunology. 236. 255–273. 19 indexed citations
5.
6.
Yang, Chao, Xiangwei Xiao, Xiaodong Zhu, et al.. (1997). Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. Journal of Virology. 71(12). 9231–9247. 144 indexed citations
7.
Ansardi, D C, et al.. (1996). Poliovirus Assembly and Encapsidation of Genomic RNA. Advances in virus research. 46. 1–68. 31 indexed citations
8.
9.
Ansardi, D C & Casey D. Morrow. (1995). Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. Journal of Virology. 69(3). 1540–1547. 27 indexed citations
10.
Ansardi, D C, et al.. (1995). Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. Journal of Virology. 69(2). 1359–1366. 9 indexed citations
11.
Morrow, Casey D., Donna C. Porter, D C Ansardi, Zina Moldoveanu, & Patricia N. Fultz. (1994). New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection.. PubMed. 10 Suppl 2. S61–6. 16 indexed citations
12.
13.
Ansardi, D C, Donna C. Porter, & Casey D. Morrow. (1993). Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. Journal of Virology. 67(6). 3684–3690. 37 indexed citations
14.
Porter, Donna C., D C Ansardi, Won Suk Choi, & Casey D. Morrow. (1993). Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. Journal of Virology. 67(7). 3712–3719. 47 indexed citations
15.
Porter, Donna C., D C Ansardi, Michael Lentz, & Casey D. Morrow. (1993). Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3Dpol. Virus Research. 29(3). 241–254. 11 indexed citations
16.
Ansardi, D C & Casey D. Morrow. (1993). Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation. Journal of Virology. 67(12). 7284–7297. 10 indexed citations
17.
Ansardi, D C, Donna C. Porter, & Casey D. Morrow. (1992). Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. Journal of Virology. 66(7). 4556–4563. 48 indexed citations
18.
Agrawal, Alok, et al.. (1992). Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.. Journal of Biological Chemistry. 267(35). 25352–25358. 39 indexed citations
19.
Ansardi, D C, Donna C. Porter, & Casey D. Morrow. (1992). Myristylation ofPoliovirus Capsid Precursor P1IsRequired for Assembly ofSubviral Particles. 1 indexed citations
20.
Ansardi, D C, Donna C. Porter, & Casey D. Morrow. (1991). Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. Journal of Virology. 65(4). 2088–2092. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna C. Porter Breakdown of academic impact, for papers by Marion S. Freistadt Breakdown of academic impact, for papers by N Moscufo Breakdown of academic impact, for papers by B M Detjen Breakdown of academic impact, for papers by I Ise Breakdown of academic impact, for papers by Christopher T. Cornell Breakdown of academic impact, for papers by Jörg Enssle Breakdown of academic impact, for papers by Sylvain de Breyne Breakdown of academic impact, for papers by Bernd Maurer Breakdown of academic impact, for papers by Hyung Suk Oh
Rankless by CCL
2026